Routine vaginal pap test is not useful in women status-post hysterectomy for benign disease

Diagnostic Cytopathology

Volumn 34, Issue 9, 2006, Pages 640-643

  Farghaly, Hanan ^a   Bourgeois, Danyel ^a   Houser, Patricia M ^a   Padmanabhan, Vijaylakshmi ^a   Lage, Janice M ^a   Hoda, Rana S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Benign hysterectomy; Usefulness; Vaginal pap

Indexed keywords

ADULT; AGE; AGED; AGING; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC VALUE; ENDOMETRIOSIS; EVALUATION; FEMALE; HUMAN; HYSTERECTOMY; LOW GRADE VAGINAL INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIAL ABNORMALITY; UTERINE CERVIX NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY WITH NONNEOPLASTIC FINDING; UTERINE CERVIX NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY WITHOUT NONNEOPLASTIC FINDING; VAGINA ATROPHY;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES; UNNECESSARY PROCEDURES; VAGINAL SMEARS;

EID: 33748047485     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20527     Document Type: Conference Paper

References (15)

1. Wright TC, Jr, Cox JT, Massad LS, et al., for the 2001 ASCCP-sponsored Consensus Conference. 2001 Consensus guidelines for the management of cervical cytological abnormalities. JAMA 2002;287:2120-2129.
2. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
3. Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-84. Am J Public Health 1988;78:852-853.
4. US Preventive Services Task Force. Screening for cervical cancer. In: Guide to clinical preventive services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996. p 105-118.
5. Pearce KF, Haefner HK, Sarwar SF, Nolan TE. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med 1996;335:1559-1562.
6. Videlefsky A, Grossl N, Denniston M, Sehgal R, Lane JM, Goodenough G. Routine vaginal cuff smear testing in post-hysterectomy patients with benign uterine conditions: When is it indicated? J Am Board Fam Pract 2000;13:233-238.
7. Piscitelli JT, Bastian LA, Wilkes A, Simel DL. Cytologic screening after hysterectomy for benign disease. Am J Obstet Gynecol 1995;173:424-432.
8. Stevermer JJ, Wung L. Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease? J Fam Pract 2001;50(2):111,112.
9. Fetters MD, Fischer G, Reed BD. Effectiveness of vaginal Papanicolaou smear screening after total hysterectomy for benign disease. Review. JAMA 1996;275:940-947.
10. Herman JM, Homesley HD, Dignan MB. Is hysterectomy a risk factor for vaginal cancer? JAMA 1986;256:601-603.
11. Bell J, Sevin BU, Averette H, Nadji M. Vaginal cancer after hysterectomy for benign disease: Value of cytologic screening. Obstet Gynecol 1984;64:699-702.
12. Stuart GCE, Allen HH, Anderson RJ. Squamous cell carcinoma of the vagina following hysterectomy. Am J Obstet Gynecol 1981;139:311-315.
13. Ferris DG, Messing MJ, Crosby JH. Vaginal intraepithelial neoplasia III detected after hysterectomy for benign conditions. J Fam Prac 1995;40:81-85. Review.
14. Dodge JA, Eltabbakh GH, Mount SL, Walker RP, Morgan A. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol 2001;83:363-369.
15. Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA 2004;291:2990-2993.